Anxiolytic-like effect of way-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: Influence of prior test experience

Brain Research

Volumn 928, Issue 1-2, 2002, Pages 50-59

  Canto de Souza, Azair ^a   Luiz Nunes de Souza, Ricardo ^b   John Rodgers, Robert ^c  

^a FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

5 HT1A receptor; Anxiety; Dorsal raphe nucleus; Elevated plus maze; Median raphe nucleus; Mice; WAY 100635

Indexed keywords

N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN; SEROTONIN 1A RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN REGION; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; IMAGE ANALYSIS; LEARNING; LOCOMOTION; MALE; MAZE TEST; MEDIAN RAPHE NUCLEUS; MESENCEPHALON; MOUSE; MOUSE STRAIN; NERVE PROJECTION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RECEPTOR BLOCKING; RISK ASSESSMENT; SEROTONIN RELEASE; TASK PERFORMANCE; TRANQUILIZING ACTIVITY; VIDEOTAPE;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MAZE LEARNING; MICE; MICROINJECTIONS; MOTOR ACTIVITY; NEURAL PATHWAYS; NEURONS; PIPERAZINES; PYRIDINES; RAPHE NUCLEI; RATS; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0037154716     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)03354-6     Document Type: Article

References (70)

1. 1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively
2. 8-Hydroxy-2-(di-n-propylamino) tetralin, a new centrally-acting 5-hydroxytryptamine receptor agonist
3. 1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties
4. 1A receptors as targets for the development of novel anxiolytic drugs: Models, mechanisms and further directions
5. 1A receptor ligands in the mouse
6. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia
7. Failure of hippocampal or raphe infusion of WAY-100635 to alter 'trial 2' plus-maze anxiety in mice
8. Different behavioural profiles of R(+)- and S(-)-enantiomers of 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) in the murine elevated plus-maze
9. 1A
10. 1A receptor antagonism on plus-maze behaviour in mice. II. WAY 100635, SDZ 216-525 and NAN-190
11. 1A receptor antagonist, in the murine elevated plus-maze
12. Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze
13. 1A receptor ligands, LY293284, LY315712 and LY297996, on plus-maze anxiety in mice
14. Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin 1A receptor agonist
15. 1A receptors in the dorsal raphe and dorsal hippocampus in anxiety assessed by the behavioral effects of 8-OH-DPAT and S 15535 in a modifed Geller-Seifter conflict model
16. An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze
17. Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: Comparison with haloperidol
18. 1A receptors that are negatively coupled to adenylate cyclase
19. 1A receptor agonists: Recent developments and controversial issues
20. 1A receptors and anxiety
21. One-trial tolerance to the anxiolytic effects of benzodiazepines in the plus-maze
22. 1A receptor ligands in dorsal raphe and ventral hippocampus
23. 1A receptor modulation of anxiety in two ethological animal tests
24. Social interaction and elevated plus-maze tests: Changes in release and uptake of 5-HT and GABA
25. Trial 2 in the elevated plus-maze: A different form of fear
26. 1A receptor antagonists: Utility as research tools and therapeutic agents
27. 1A receptor antagonist
28. 1A antagonist, increases serotonergic neuronal activity in behaving cats: Comparison with (S)-WAY-100135
29. 1A receptor antagonist, WAY-100635
30. The comparative efficacy of buspirone and diazepam in the treatment of anxiety
31. 1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze
32. 1A receptor function: A link between anxiety and depression?
33. Role of 5-HT in stress, anxiety and depression
34. 5-Hydroxytrptamine-interacting drugs in animal models of anxiety: More than 30 years of research
35. 1A receptor antagonists
36. 1A receptor antagonists in three rat models of anxiety
37. The use of the rat plus-maze to discriminate non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands
38. Behavioural and biochemical consequences following activation of the 5-HT1-like and GABA receptors in the dorsal raphe nucleus of the rat
39. Contrasting behavioural effects of 8-OH-DPAT in the dorsal raphe nucleus and ventral hippocampus
40. Responses of Swiss-Webster mice to repeated plus-maze experience: Further evidence for a qualittive shift in emotional state?
41. 1B recognition sites
42. 5-HT and anxiety
43. 1A receptor agonists and their inhibitory effects on the firing of serotonergic neurons in the rat?
44. 1A receptor antagonists and their interaction on the fear-potentiated startle response
45. The use of a plus-maze to measure anxiety in the mouse
46. 1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT
47. The septum and the hippocampus differentially mediate anxiolytic effects of R(+)-8-OH-DPAT
48. Effects of centrally administered anxiolytic compounds in animal models of anxiety
49. 1A receptor antagonist (S)-UH-301 in rodents and monkeys
50. 1A antagonists WAY 100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing
51. Effects of beta-adrenoceptor ligands in the elevated X-maze 'anxiety' model and antagonism of the 'anxiogenic' response to 8-OH-DPAT
52. Anxiolytic-like effect of WAY-100635 microinfusions into ventral but not dorsal hippocampus in mice
53. Anxiety-induced antinociception in mice: Effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam
54. Serotonin receptors in the human brain III. Autoradiographic mapping of serotonin-1 receptors
55. 1A receptors
56. 1A receptor modulators
57. 1A receptor antagonists
58. 1A receptor antagonist, in the murine elevated plus-maze test
59. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety
60. 1A receptor antagonists
61. 1A receptors play an important role in modulation of behavior of rats in a two-compartment black and white box
62. 1A receptor agonists 8-OH-DPAT, ipsapirone and buspirone in the rat
63. 1 autoreceptors: Parallel purposes or pointless plurality?
64. 1A receptor agonists
65. Anxiogenic stimuli in the elevated plus-maze
66. Projections of the median raphe nucleus in the rat
67. Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze
68. Behavioral effects of intra-amygdala injections of GABA and 5-HT acting drugs in the elevated plus-maze